About us

MC Sciences is driven by a world-class team of leading drug development, science, medical and execution capabilities, and guided by board chairman Dr. Mikael Dolsten, former worldwide CSO of Pfizer.

Founded by Prof. Gerhard J. Molderings and the CEO Wolfgang Taumann, MC Sciences continues to be on track as emerging biotech company extensively expanding our leadership and drug development capabilities to advance our promising novel mast therapeutics to clinics.

MC Sciences is headquartered in Germany, with operations in Naples, Florida, and backed by ROC Venture Group. 

Aaron Stafford, Managing Partner of ROC Venture Group: “As early investors, we believed in Wolfgang’s vision and Leadership capabilities, and the enormous potential of MC Sciences from day one. MC Sciences has surpassed every milestone demonstrating extraordinary capital efficiency and proof of concept. It’s the kind of opportunity that doesn’t come around often, and we’re incredibly proud to have backed it early.”